Jw Pharmaceutical
Clinical trials sponsored by Jw Pharmaceutical, explained in plain language.
-
New drug aims to stop heavy periods caused by fibroids
Disease control Recruiting nowThis study tests a new pill called KLH-2109 to see if it can reduce heavy menstrual bleeding in people with uterine fibroids (non-cancerous growths in the uterus). About 254 participants will take either the new drug or a standard treatment. Researchers will track bleeding levels…
Phase: PHASE3 • Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated May 17, 2026 00:27 UTC
-
New combo therapy aims to smooth blood sugar swings in diabetes
Disease control Recruiting nowThis study tests whether adding another drug to metformin and an SGLT-2 inhibitor can improve blood sugar stability in people with type 2 diabetes. About 178 adults with poor blood sugar control will receive the combination therapy for 12 weeks. The main goal is to see if it redu…
Phase: PHASE4 • Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New combo pill targets cholesterol in metabolic syndrome patients
Disease control Recruiting nowThis study is testing a combination pill (Pitavastatin/Ezetimibe) to lower cholesterol in 10,000 adults who have both high cholesterol and metabolic syndrome. Researchers will measure how much LDL-C (bad cholesterol) drops after 24 and 48 weeks, and check for side effects. Partic…
Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New combo pill aims to tackle two heart risks at once
Disease control Recruiting nowThis study tests whether taking two medications together (JW0104 and C2402) is safe and effective for people with both high blood pressure and high cholesterol. About 162 adults will receive either the combo or a placebo. The goal is to see if the combo lowers blood pressure and …
Phase: PHASE3 • Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New skin cream tested on healthy people – no cure expected
Knowledge-focused Recruiting nowThis early-stage study tests whether a new topical drug called JW0061 is safe for healthy adults. About 104 Korean and Caucasian volunteers will receive either the drug or a placebo cream. The goal is to check for side effects and how the body processes the drug, not to treat any…
Phase: PHASE1 • Sponsor: JW Pharmaceutical • Aim: Knowledge-focused
Last updated May 17, 2026 00:29 UTC